Skip to content

Is Rifaximin the Same as Xifaxan? Understanding the Brand vs. Generic Distinction

4 min read

Over 97% of an oral dose of rifaximin is recovered in the feces, underscoring its minimal systemic absorption and localized action within the gastrointestinal tract. This unique characteristic is key to understanding the relationship between the active ingredient rifaximin and its brand-name counterpart, Xifaxan.

Quick Summary

Rifaximin is the active ingredient in the brand-name medication Xifaxan. While essentially the same drug, Xifaxan is the proprietary, branded version, whereas rifaximin is the generic name. Xifaxan is used to treat specific gastrointestinal conditions like IBS-D and hepatic encephalopathy.

Key Points

  • Brand-Generic Identity: Rifaximin is the active chemical ingredient, and Xifaxan is the brand name, meaning they are the same drug.

  • Low Absorption: Rifaximin is minimally absorbed into the bloodstream and acts locally in the gut, making it a targeted therapy for GI issues.

  • FDA-Approved Uses: The medication is approved for treating traveler's diarrhea, IBS-D, and preventing hepatic encephalopathy recurrence.

  • No US Generic: Currently, no generic version of Xifaxan is available in the United States, so the brand-name product must be used.

  • Targeted Action: The drug works by inhibiting the RNA synthesis of certain gut bacteria, thus controlling conditions linked to bacterial imbalance.

  • Favorable Side Effect Profile: Due to low systemic exposure, rifaximin has a generally well-tolerated side effect profile, mainly affecting the GI system.

In This Article

Rifaximin and Xifaxan: A Brand and Generic Relationship

For many medications, the relationship between the generic and brand names is simple: they are two different labels for the same active ingredient. When asked, “Is rifaximin the same as Xifaxan?”, the answer is yes, with the important caveat that rifaximin is the active pharmaceutical ingredient, and Xifaxan is the brand name under which it is marketed. This distinction is crucial for understanding how the drug works, its uses, and its availability.

Xifaxan is manufactured by Salix Pharmaceuticals and holds the patent for the drug in the United States, meaning there is no therapeutically equivalent generic version of Xifaxan available in the U.S. at this time. For a prescription to be filled as Xifaxan, the pharmacist must dispense the brand-name product from the manufacturer. This differs from other common medications, where a pharmacist can substitute a less expensive generic version unless specifically prohibited by the prescriber.

The Unique Pharmacology of Rifaximin

Rifaximin belongs to the rifamycin class of antibiotics, a group of drugs that inhibit bacterial RNA synthesis by binding to the beta-subunit of bacterial DNA-dependent RNA polymerase. What sets rifaximin apart from other antibiotics, especially other rifamycins like rifampin, is its extremely low oral bioavailability. This means that when taken by mouth, very little of the drug is absorbed into the bloodstream. Instead, it remains concentrated in the gastrointestinal (GI) tract where it exerts its effects.

This localized action is particularly beneficial because it allows the medication to target bacteria in the gut with minimal systemic exposure. This reduces the risk of widespread side effects and, importantly, lessens the potential for the development of antibiotic resistance in bacteria outside the GI tract. Rifaximin’s activity is broad-spectrum, covering a wide range of aerobic and anaerobic, Gram-positive and Gram-negative bacteria.

FDA-Approved Uses for Xifaxan (Rifaximin)

The specific, localized action of rifaximin in the gut makes it an effective treatment for several gastrointestinal and liver-related conditions. The FDA-approved indications for Xifaxan include:

  • Traveler's Diarrhea (TD) caused by E. coli: In adults and children 12 years and older, Xifaxan is prescribed for a three-day course to treat TD caused by noninvasive strains of E. coli. It is important to note that it is not effective for diarrhea accompanied by fever or blood in the stool, as these may indicate a different type of infection.
  • Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults: Xifaxan is used to treat the symptoms of IBS-D, such as abdominal pain and bloating. The typical treatment is a 14-day course, which can be repeated if symptoms return.
  • Reduction in Risk of Overt Hepatic Encephalopathy (HE) Recurrence in Adults: In patients with severe liver disease, toxins like ammonia can build up in the bloodstream and affect the brain, leading to HE. Rifaximin works by reducing the gut bacteria that produce these toxins, thereby reducing the risk of HE episodes.

Potential Side Effects of Xifaxan

Because of its low absorption, rifaximin has a favorable side effect profile compared to other antibiotics. Many of the reported side effects can also be symptoms of the underlying condition being treated. Common side effects may include:

  • Nausea
  • Peripheral edema (swelling of the ankles or lower limbs)
  • Constipation
  • Fatigue
  • Dizziness
  • Abdominal pain

More serious, though rare, side effects can occur, including Clostridioides difficile infection (CDI), which can lead to severe diarrhea. Patients should contact their doctor if they experience severe or bloody diarrhea while taking the medication.

Comparison: Rifaximin (Active Ingredient) vs. Xifaxan (Brand Name)

Feature Rifaximin (Generic Name) Xifaxan (Brand Name)
Classification The chemical name for the active antibiotic compound. The proprietary name under which the drug is sold by Salix Pharmaceuticals.
Active Ingredient Rifaximin. Rifaximin.
Formulation Not available as a generic formulation in the U.S. A generic version would contain the same active ingredient. Currently available in 200 mg and 550 mg oral tablets.
Availability Not currently available as a lower-cost generic in the U.S. Patients requiring the drug must purchase the brand-name version. Only available by prescription. Costs can be high without insurance, but savings programs may be available.
Cost Hypothetically lower cost once a generic becomes available. Brand-name pricing, which is typically more expensive than generic equivalents.

Conclusion: Rifaximin is Xifaxan's Active Component

The fundamental takeaway is that rifaximin is indeed the same drug as Xifaxan in terms of its active ingredient and therapeutic action. Xifaxan is simply the brand name for rifaximin, much like how ibuprofen is the generic name for Advil. The low systemic absorption of this drug is a defining characteristic of its pharmacology, allowing it to target bacteria in the gut while minimizing systemic side effects. For patients in the United States, Xifaxan remains the only option for obtaining prescription rifaximin, as a therapeutically equivalent generic is not yet available. Anyone prescribed this medication should understand the brand and generic relationship, as well as the drug's purpose for their specific condition, whether it be IBS-D, HE, or traveler's diarrhea. For further information, consulting resources like the U.S. National Library of Medicine's MedlinePlus drug information page can be helpful.

Rifaximin vs. Xifaxan: Essential Takeaways

  • Brand vs. Generic: Rifaximin is the generic, active ingredient, while Xifaxan is the brand name sold by Salix Pharmaceuticals.
  • Same Drug, Different Name: The two names refer to the exact same medication and therapeutic substance.
  • Gastrointestinal Focus: The drug's low systemic absorption ensures it primarily acts locally within the GI tract.
  • No U.S. Generic Available: In the United States, there is currently no generic version of rifaximin available, making Xifaxan the only option.
  • Specific Uses: The medication is prescribed for specific conditions, including traveler's diarrhea, IBS-D, and hepatic encephalopathy.
  • Consult a Healthcare Provider: As with any medication, it is vital to follow a doctor's instructions and not to self-diagnose or self-treat with rifaximin/Xifaxan.

Frequently Asked Questions

No, currently, there is no therapeutically equivalent generic version of Xifaxan available in the United States.

Rifaximin is the generic name for the active drug, while Xifaxan is the brand name. The drug itself is the same active compound.

Xifaxan is FDA-approved to treat irritable bowel syndrome with diarrhea (IBS-D), traveler's diarrhea caused by E. coli, and to reduce the risk of hepatic encephalopathy recurrence in adults.

Rifaximin works by inhibiting bacterial RNA synthesis in the gut. Because it is poorly absorbed, its effects are localized to the gastrointestinal tract, minimizing systemic impact.

The most common side effects include nausea, peripheral edema, constipation, fatigue, and dizziness.

No. Xifaxan is specifically for traveler's diarrhea caused by noninvasive E. coli strains. It is not effective for diarrhea with fever or blood in the stool.

Yes, Xifaxan is an antibiotic. It belongs to the rifamycin class and works by stopping the growth of certain bacteria in the gut.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.